Person

Gregg H. Alton

Formerly Chief Patient Officer, Gilead Sciences

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$30.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 1, 2018GILDSale3,099$79.41$246K
Mar 1, 2018GILDSale16,200$78.92$1.3M
Mar 1, 2018GILDSale5,701$77.64$443K
Feb 20, 2018GILDSale14,435$81.54$1.2M
Feb 1, 2018GILDSale9,786$83.29$815K
Feb 1, 2018GILDSale15,214$83.66$1.3M
Jan 11, 2018GILDSale7,501$79.00$593K
Jan 11, 2018GILDSale18,374$79.00$1.5M
Jan 11, 2018GILDSale4,125$79.00$326K
Jan 2, 2018GILDSale5,675$73.86$419K
Jan 2, 2018GILDSale700$72.34$51K
Jan 2, 2018GILDSale8,625$74.00$638K
Dec 1, 2017GILDSale3,600$75.20$271K
Dec 1, 2017GILDSale11,400$74.46$849K
Nov 1, 2017GILDSale13,400$74.74$1.0M
Nov 1, 2017GILDSale1,600$75.48$121K
Oct 2, 2017GILDSale2,141$83.52$179K
Oct 2, 2017GILDSale19,938$82.68$1.6M
Oct 2, 2017GILDSale2,921$81.84$239K
Sep 1, 2017GILDSale21,263$82.96$1.8M
Sep 1, 2017GILDSale3,737$83.54$312K
Aug 30, 2017GILDSale50,000$79.00$4.0M
Aug 1, 2017GILDSale15,000$75.88$1.1M
Jul 21, 2017GILDSale34,500$74.00$2.6M
Jul 21, 2017GILDSale5,500$74.00$407K
Jul 3, 2017GILDSale5,000$71.06$355K
Jun 1, 2017GILDSale5,000$65.02$325K
May 1, 2017GILDSale5,000$68.31$342K
Mar 30, 2017GILDSale5,000$67.48$337K
Nov 9, 2016GILDSale10,000$79.00$790K
Sep 22, 2016GILDSale5,000$81.84$409K
Apr 19, 2016GILDSale35,874$100.02$3.6M
Apr 19, 2016GILDSale4,126$100.00$413K
Apr 1, 2016GILDSale5,000$91.23$456K
Mar 14, 2016GILDSale5,000$90.00$450K

SEC reporting-owner ID (CIK) 1334682 · all filings on EDGAR